|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.280 USD | +7.04% |
|
+9.09% | +49.02% |
| 06-15 | Compugen Ltd. - Special Call | |
| 06-11 | Compugen Presents Trial-In-Progress Poster On MAIA-Ovarian Phase 1 Study Of COM701 At ESMO Gynaecological Cancers Congress 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMPUGEN LTD. | Other Biotechnology & Medical Research | +7.04% | +9.09% | +49.02% | +29.55% | -71.57% | 216M |  |  | |
- Stock Market
- Stocks
- CGEN Stock
- Charts Compugen Ltd.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
